Cited by 441Bacterial Cancer TherapyAmino Acid Enzymes and MetabolismPolyamine Metabolism and Applications

The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.

Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer

Open access

Delage, Barbara, Fennell, Dean A., Nicholson, Linda, McNeish, Iain, Lemoine, Nicholas R., Crook, Tim, Szlosarek, Peter W.·2010·International Journal of Cancer

DOI 10.1002/ijc.25202

Open this paper in CoChat — free account Open PDF

Abstract

Arginine, a semi‐essential amino acid in humans, is critical for the growth of human cancers, particularly those marked by de novo chemoresistance and a poor clinical outcome. In addition to protein synthesis, arginine is involved in diverse aspects of tumour metabolism, including the synthesis of nitric oxide, polyamines, nucleotides, proline and glutamate. Tumoural downregulation of the enzyme argininosuccinate synthetase (ASS1), a recognised rate‐limiting step in arginine synthesis, results in an intrinsic dependence on extracellular arginine due to an inability to synthesise arginine for growth. This dependence on extracellular arginine is known as arginine auxotrophy. Several tumours are arginine auxotrophic, due to variable loss of ASS1, including hepatocellular carcinoma, malignant melanoma, malignant pleural mesothelioma, prostate and renal cancer. Importantly, targeting extracellular arginine for degradation in the absence of ASS1 triggers apoptosis in arginine auxotrophs. Several phase I/II clinical trials of the arginine‐lowering drug, pegylated arginine deiminase, have shown encouraging evidence of clinical benefit and low toxicity in patients with ASS1‐negative tumours. In part, ASS1 loss is due to epigenetic silencing of the ASS1 promoter in various human cancer cell lines and tumours, and it is this silencing that confers arginine auxotrophy. In relapsed ovarian cancer, this is associated with platinum refractoriness. In contrast, several platinum sensitive tumours, including primary ovarian, stomach and colorectal cancer, are characterised by ASS1 overexpression, which is regulated by proinflammatory cytokines. This review examines the prospects for novel approaches in the prevention, diagnosis and treatment of malignant disease based on ASS1 pathophysiology and its rate‐limiting product, arginine.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/ijc.25202

Cites

86 of 86 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Arginine metabolism: nitric oxide and beyond
WU, G., & MORRIS, S. M. (1998) · Biochemical Journal · doi:10.1042/bj3360001 · Cited by 2,811
Tumor cell metabolism: cancer's Achilles' heel
Kroemer, G., & Pouyssegur, J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.005 · Cited by 2,337
Regulation of immune responses by L-arginine metabolism
Bronte, V., & Zanovello, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1668 · Cited by 1,775
The role of nitric oxide in tumour progression
Fukumura, D., Kashiwagi, S., & Jain, R. K. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1910 · Cited by 1,279
Polyamines and cancer: old molecules, new understanding
Gerner, E. W., & Meyskens, F. L. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1454 · Cited by 1,163
Brick by brick: metabolism and tumor cell growth
DeBerardinis, R. J., Sayed, N., Ditsworth, D., & Thompson, C. B. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.02.003 · Cited by 1,018
Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives
Rodrı́guez, P. C., & Ochoa, A. C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00608.x · Cited by 743
Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages
Xia, Y., & Zweier, J. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6954 · Cited by 691
Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial
Meyskens, F. L., McLaren, C. E., Pelot, D., Fujikawa-Brooks, S., Carpenter, P. M., Hawk, E. T., Kelloff, G. J., Lawson, M. J., Kidao, J., McCracken, J., et al. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0042 · Cited by 518
Recent advances in arginine metabolism: roles and regulation of the arginases
Morris Jr, S. M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00278.x · Cited by 485
Autophagy Is Required for Maintenance of Amino Acid Levels and Protein Synthesis under Nitrogen Starvation
Onodera, J., & Ohsumi, Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506736200 · Cited by 453
Autocrine Glutamate Signaling Promotes Glioma Cell Invasion
Lyons, S. A., Chung, W. J., Weaver, A. K., Ogunrinu, T., & Sontheimer, H. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2034 · Cited by 342
Argininosuccinate synthetase from the urea cycle to the citrulline–NO cycle
Husson, A., Brasse‐Lagnel, C., Fairand, A., Renouf, S., & Lavoinne, A. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03559.x · Cited by 335
Arginine Deiminase as a Novel Therapy for Prostate Cancer Induces Autophagy and Caspase-Independent Apoptosis
Kim, R. H., Coates, J. M., Bowles, T. L., McNerney, G. P., Sutcliffe-Goulden, J., Jung, J. U., Gandour‐Edwards, R. F., Chuang, F. Y. S., Bold, R. J., & Kung, H.-J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3157 · Cited by 321
Incidence and distribution of argininosuccinate synthetase deficiency in human cancers
Dillon, B. J., Prieto, V. G., Curley, S. A., Ensor, M., Holtsberg, F. W., Bomalaski, J. S., & Clark, M. A. (2004) · Cancer · doi:10.1002/cncr.20057 · Cited by 317
Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo.
Ensor, M., Holtsberg, F. W., Bomalaski, J. S., & Clark, M. A. (2002) · PubMed · Cited by 315
Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia
Pollock, P. M., Cohen-Solal, K., Sood, R. B., Namkoong, J., Martino, J. J., Koganti, A., Zhu, H., Robbins, C. M., Makałowska, I., Shin, S., et al. (2003) · Nature Genetics · doi:10.1038/ng1148 · Cited by 306
Plasma Membrane Transporters for Arginine
Closs, E. I., Simon, A., Vékony, N., & Rotmann, A. (2004) · Journal of Nutrition · doi:10.1093/jn/134.10.2752s · Cited by 297
Pegylated Recombinant Human Arginase (rhArg-peg5,000mw) Inhibits the In vitro and In vivo Proliferation of Human Hepatocellular Carcinoma through Arginine Depletion
Cheng, P., Lam, T. L., Lam, W.-M., Tsui, S. M., Cheng, A. W. M., Lo, W. H., & Leung, Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1945 · Cited by 280
The metabolism of proline, a stress substrate, modulates carcinogenic pathways
Phang, J. M., Donald, S. P., Pandhare, J., & Liu, Y. (2008) · Amino Acids · doi:10.1007/s00726-008-0063-4 · Cited by 252
Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies
Izzo, F., Marra, P., Beneduce, G., Castello, G., Vallone, P., De Rosa, V., Cremona, F., Ensor, C. M., Holtsberg, F. W., Bomalaski, J. S., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.120 · Cited by 250
Asparagine Synthetase Chemotherapy
Richards, N. G. J., & Kilberg, M. S. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142520 · Cited by 244
Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies
Ascierto, P. A., Scala, S., Castello, G., Daponte, A., Simeone, E., Ottaiano, A., Beneduce, G., De Rosa, V., Izzo, F., Melucci, M. T., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.0933 · Cited by 238
Arginine Deprivation as a Targeted Therapy for Cancer
Feun, L. G., You, M., Wu, C., Kuo, M. T., Wangpaichitr, M., Spector, S. A., & Savaraj, N. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784246199 · Cited by 236
Coinduction of nitric oxide synthase and argininosuccinate synthetase in a murine macrophage cell line. Implications for regulation of nitric oxide production.
Nussler, A. K., Billiar, T. R., Liu, Z. Z., & Morris, S. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42251-4 · Cited by 217
Metabolic enzymes as oncogenes or tumor suppressors
Thompson, C. B. (2009) · New England Journal of Medicine · doi:10.1056/nejme0810213 · Cited by 213
Hepatic glutamate metabolism: a tale of 2 hepatocytes
Brosnan, M. E., & Brosnan, J. T. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27462z · Cited by 199
Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells.
Singh, R., Pervin, S., Karimi, A., Cederbaum, S. D., & Chaudhuri, G. (2000) · PubMed · Cited by 185
In vivo Loss of Expression of Argininosuccinate Synthetase in Malignant Pleural Mesothelioma Is a Biomarker for Susceptibility to Arginine Depletion
Szlosarek, P. W., Klampatsa, A., Pallaska, A., Sheaff, M. T., Smith, P., Crook, T., Grimshaw, M. J., Steele, J. P. C., Rudd, R., Balkwill, F. R., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1101 · Cited by 181
Self-citation
Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation via arginine deiminase
Yoon, C., Shim, Y., Kim, E., Lee, J., Won, N., Kim, J., Park, I., Yoon, D., & Min, B. (2007) · International Journal of Cancer · doi:10.1002/ijc.22322 · Cited by 165
Molecular profiling of platinum resistant ovarian cancer
Helleman, J., Jansen, M. P. H. M., Span, P. N., van Staveren, I. L., Massuger, L. F. A. G., Gelder, M. E. M., Sweep, F. C. G. J., Ewing, P. C., van der Burg, M. E. L., Stoter, G., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21599 · Cited by 165
A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients
Yang, T., Lu, S., Chao, Y., Sheen, I.-S., Lin, C.-C., Wang, T., Chen, S.-C., Wang, J., Liao, L.-Y., Thomson, J. A., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605856 · Cited by 160
Internal Ribosome Entry Site-mediated Translation of a Mammalian mRNA Is Regulated by Amino Acid Availability
Fernandez, J., Yaman, İ., Mishra, R., Merrick, W. C., Snider, M. D., Lamers, W. H., & Hatzoglou, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009714200 · Cited by 154
Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase
Bowles, T. L., Kim, R., Galante, J., Parsons, C. M., Virudachalam, S., Kung, H., & Bold, R. J. (2008) · International Journal of Cancer · doi:10.1002/ijc.23723 · Cited by 153
Plasma arginine concentrations are reduced in cancer patients: evidence for arginine deficiency?
Vissers, Y. L. J., Dejong, C. H. C., Luiking, Y. C., Fearon, K. C. H., MEYENFELDT, M. F. V., & Deutz, N. E. P. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.5.1142 · Cited by 150
Resistance to arginine deiminase treatment in melanoma cells is associated with induced argininosuccinate synthetase expression involving c-Myc/HIF-1α/Sp4
Tsai, W.-B., Aiba, I., Lee, S.-Y., Feun, L. G., Savaraj, N., & Kuo, M. T. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0794 · Cited by 143
Tumor iNOS predicts poor survival for stage III melanoma patients
Ekmekçioglu, S., Ellerhorst, J. A., Prieto, V. G., Johnson, M. M., Broemeling, L. D., & Grimm, E. A. (2006) · International Journal of Cancer · doi:10.1002/ijc.21767 · Cited by 135
Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer
Nicholson, L. J., Smith, P. R., Hiller, L., Szlosarek, P. W., Kimberley, C., Sehouli, J., Koensgen, D., Mustea, A., Schmid, P., & Crook, T. (2009) · International Journal of Cancer · doi:10.1002/ijc.24546 · Cited by 133
Self-citation
Metabolic Targeting as an Anticancer Strategy: Dawn of a New Era?
Pan, J. G., & Mak, T. W. (2007) · Science s STKE · doi:10.1126/stke.3812007pe14 · Cited by 129
Cloning of cDNA for argininosuccinate synthetase mRNA and study of enzyme overproduction in a human cell line.
Su, T. S., Bock, H. G., O’Brien, W. E., & Beaudet, A. L. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68480-2 · Cited by 128
Pegylated arginine deiminase: a novel anticancer enzyme agent
Feun, L. G., & Savaraj, N. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.7.815 · Cited by 118
Cancer incidence in British vegetarians
Key, T. J., Appleby, P. N., Spencer, E. A., Travis, R. C., Allen, N. E., Thorogood, M., & Mann, J. I. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605098 · Cited by 116
Insulin and the arginine paradox.
Kurz, S. D., & Harrison, D. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119166 · Cited by 112
Proteomic Expression Analysis of Surgical Human Colorectal Cancer Tissues: Up-Regulation of PSB7, PRDX1, and SRP9 and Hypoxic Adaptation in Cancer
Rho, J.-H., Qin, S., Wang, J. Y., & Roehrl, M. H. A. (2008) · Journal of Proteome Research · doi:10.1021/pr8000892 · Cited by 101
Argininosuccinate Synthase Expression Is Required to Maintain Nitric Oxide Production and Cell Viability in Aortic Endothelial Cells
Goodwin, B. L., Solomonson, L. P., & Eichler, D. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308160200 · Cited by 100
Arginine deiminase: a potential inhibitor of angiogenesis and tumour growth
Is, P., Kang, S.-W., Shin, Y.-J., Chae, K.-Y., Park, M.-O., Kim, M. Y., Wheatley, D. N., & Min, B.-H. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601181 · Cited by 97
Agmatine: At the Crossroads of the Arginine Pathways
Satriano, J. A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1304.004 · Cited by 96
Induction of spermidine/spermine N1-acetyltransferase (SSAT) by aspirin in Caco-2 colon cancer cells
Babbar, N., Gerner, E. W., & Casero, R. A. (2006) · Biochemical Journal · doi:10.1042/bj20051298 · Cited by 95
Regulation of RARβ expression by RAR- and RXR-selective retinoids in human lung cancer cell lines: Effect on growth inhibition and apoptosis induction
Li, Y., Dawson, M. I., Agadir, A., Lee, M., Jong, L., Hobbs, P. D., & Zhang, X.-K. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980105)75:1 · Cited by 94
Depletion of Endogenous Nitric Oxide Enhances Cisplatin-induced Apoptosis in a p53-dependent Manner in Melanoma Cell Lines
Tang, C., & Grimm, E. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m310821200 · Cited by 90
New indications and controversies in arginine therapy
Coman, D. J., Yaplito‐Lee, J., & Boneh, A. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.05.007 · Cited by 87
Argininosuccinate Synthetase is Reversibly Inactivated by S-Nitrosylation in Vitro and in Vivo
Hao, G., Xie, L., & Gross, S. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404866200 · Cited by 85
Nutritional and Metabolic Responses to Arginine Deficiency in Carnivores
Morris, J. G. (1985) · Journal of Nutrition · doi:10.1093/jn/115.4.524 · Cited by 80
Argininosuccinate Synthetase Overexpression in Vascular Smooth Muscle Cells Potentiates Immunostimulant-induced NO Production
Xie, L., & Gross, S. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16624 · Cited by 77
Arginine Deiminase Inhibits Cell Proliferation by Arresting Cell Cycle and Inducing Apoptosis
Gong, H., Zölzer, F., Recklinghausen, G. V., Rössler, J. K., Breit, S., Havers, W., Fotsis, T., & Schweigerer, L. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1004 · Cited by 76
Controlling cancer by restricting arginine availability–arginine-catabolizing enzymes as anticancer agents
Wheatley, D. N. (2004) · Anti-Cancer Drugs · doi:10.1097/00001813-200410000-00002 · Cited by 74
Depletion of Dietary Arginine Inhibits Growth of Metastatic Tumor
Yeatman, T. J. (1991) · Archives of Surgery · doi:10.1001/archsurg.1991.01410350066010 · Cited by 67
Resistance to the anti-proliferative activity of recombinant arginine deiminase in cell culture correlates with the endogenous enzyme, argininosuccinate synthetase
Shen, L.-J., Lin, W.-C., Beloussow, K., & Shen, W.-C. (2003) · Cancer Letters · doi:10.1016/s030-43835(02)00693-6 · Cited by 66
The two-way flux of cationic amino acids across the plasma membrane of mammalian cells is largely explained by a single transport system.
White, M. F., & Christensen, H. N. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33986-3 · Cited by 63
Aberrant regulation of argininosuccinate synthetase by TNF‐α in human epithelial ovarian cancer
Szlosarek, P. W., Grimshaw, M. J., Wilbanks, G. D., Hagemann, T., Wilson, J. L., Burke, F., Stamp, G., & Balkwill, F. R. (2007) · International Journal of Cancer · doi:10.1002/ijc.22666 · Cited by 61
Self-citation
Arginine deiminase and other antiangiogenic agents inhibit unfavorable neuroblastoma growth: Potentiation by irradiation
Gong, H., Pöttgen, C., Stüben, G., Havers, W., Stuschke, M., & Schweigerer, L. (2003) · International Journal of Cancer · doi:10.1002/ijc.11298 · Cited by 53
Role of polyamines in arginine‐dependent colon carcinogenesis in ApcMin/+ mice
Yerushalmi, H. F., Besselsen, D. G., Ignatenko, N. A., Blohm-Mangone, K. A., Padilla‐Torres, J., Stringer, D. E., Guillen, J. M., Holubec, H., Payne, C. M., & Gerner, E. W. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20246 · Cited by 51
Modulation of Cellular Proliferation Alters Glutamine Transport and Metabolism in Human Hepatoma Cells
Bode, B. P., & Souba, W. W. (1994) · Annals of Surgery · doi:10.1097/00000658-199410000-00001 · Cited by 49
l -Arginine Reduces Cell Proliferation and Ornithine Decarboxylase Activity in Patients with Colorectal Adenoma and Adenocarcinoma
Ma, Q., Wang, Y., Gao, X., Ma, Z., & Song, Z. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0751 · Cited by 46
Molecular Basis for the Antiproliferative Effect of Agmatine in Tumor Cells of Colonic, Hepatic, and Neuronal Origin
Wolf, C., Brüss, M., Hanisch, B. W., Göthert, M., von Kügelgen, I., & Molderings, G. J. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.028449 · Cited by 45
Arginine revisited: Minireview article
GRILLO, M. A., & Colombatto, S. (2004) · Amino Acids · doi:10.1007/s00726-004-0081-9 · Cited by 44
Structure of human argininosuccinate synthetase
Karlberg, T., Collins, R., van den Berg, S., Flores, A., Hammarström, M., Högbom, M., Schiavone, L. H., & Uppenberg, J. (2008) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444907067455 · Cited by 40
The role of NO synthases in arginine-dependent small intestinal and colonic carcinogenesis
Yerushalmi, H. F., Besselsen, D. G., Ignatenko, N. A., Blohm-Mangone, K. A., Padilla‐Torres, J., Stringer, D. E., Cui, H., Holubec, H., Payne, C. M., & Gerner, E. W. (2005) · Molecular Carcinogenesis · doi:10.1002/mc.20168 · Cited by 38
The FKBP-associated protein FAP48 is an antiproliferative molecule and a player in T cell activation that increases IL2 synthesis
Krummrei, U., Baulieu, É.-É., & Chambraud, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438007100 · Cited by 38
Hypoxia inhibits L-arginine synthesis from L-citrulline in porcine pulmonary artery endothelial cells
Su, Y., & Block, E. R. (1995) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1995.269.5.l581 · Cited by 37
The influence of arginine upon the growth rate of a transplantable tumour in the mouse
Gilroy, E. (1930) · Biochemical Journal · doi:10.1042/bj0240589 · Cited by 35
Glutamine and interleukin‐1β interact at the level of Sp1 and nuclear factor‐κB to regulate argininosuccinate synthetase gene expression
Brasse‐Lagnel, C., Lavoinne, A., Loeber, D., Fairand, A., Bôle‐Feysot, C., Deniel, N., & Husson, A. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.06047.x · Cited by 35
Analysis of Gene Expression Identifies Differentially Expressed Genes and Pathways Associated with Lymphatic Dissemination in Patients with Adenocarcinoma of the Esophagus
Lagarde, S. M., van Themaat, P. E. V. L., Moerland, P. D., Gilhuijs-Pederson, L. A., ten Kate, F. J. W., Reitsma, P. H., van Kampen, A. H. C., Zwinderman, A. H., Baas, F., & van Lanschot, J. J. B. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0165-y · Cited by 33
Sources of nitrogen as rate-limiting factors for purine biosynthesis de novo in Ehrlich ascites tumor cells
Fontenelle, L. J., & Henderson, J. F. (1969) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(69)90067-1 · Cited by 30
Activation of caspase-3 activity and apoptosis in MDA-MB-468 cells by Nω-hydroxy-L-arginine, an inhibitor of arginase, is not solely dependent on reduction in intracellular polyamines
Singh, R., Pervin, S., Wu, G., & Chaudhuri, G. (2001) · Carcinogenesis · doi:10.1093/carcin/22.11.1863 · Cited by 28
Engineering an Arginine Catabolizing Bioconjugate: Biochemical and Pharmacological Characterization of PEGylated Derivatives of Arginine Deiminase from Mycoplasma arthritidis
Wang, M., Basu, A., Palm, T., Hua, J., Youngster, S. K., Hwang, L. A., Liu, H.-C., Li, X., Peng, P., Zhang, Y., et al. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060198y · Cited by 27
Enhanced hepatic amino acid transport in tumor-bearing rats is partially blocked by antibody to tumor necrosis factor.
Inoue, Y., Bode, B. P., Copeland, E. M., & Souba, W. W. (1995) · PubMed · Cited by 24
Effect of DNA conformation on cisplatin adduct formation
Bubley, G. J., Xu, J. Y., Kupiec, N., Sanders, D. A., Foss, F. M., O'Brien, M., Emi, Y., Teicher, B. A., & Patierno, S. R. (1996) · Biochemical Pharmacology · doi:10.1016/s0006-2952(95)02256-2 · Cited by 22
Reduced citrulline availability by OTC deficiency in mice is related to reduced nitric oxide production
Luiking, Y. C., Hallemeesch, M. M., van de Poll, M. C. G., Dejong, C. H. C., de Jonge, W. J., Lamers, W. H., & Deutz, N. E. P. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00055.2008 · Cited by 20
Elevated plasma arginase-1 does not affect plasma arginine in patients undergoing liver resection
van de Poll, M. C. G., Hanssen, S. J., Berbée, M., Deutz, N. E. P., Monbaliu, D. R. L., Buurman, W. A., & Dejong, C. H. C. (2008) · Clinical Science · doi:10.1042/cs20070143 · Cited by 20
Kinetics of incorporation of L-arginine-U-C14 into nuclear proteins of tumors and other tissues in vitro.
Starbuck, W. C., & Busch, H. (1960) · PubMed · Cited by 15
Nitric oxide synthase is induced in tumor promoter-sensitive, but not tumor promoter-resistant, JB6 mouse epidermal cells cocultured with interferon-gamma-stimulated RAW 264.7 cells: the role of tumor necrosis factor-alpha.
Murakami, A., Kawabata, K., Koshiba, T., Gao, G., Nakamura, Y., Koshimįzu, K., & Ohigashi, H. (2000) · PubMed · Cited by 15
Metabolic cooperation between argininosuccinate synthetase and argininosuccinate lyase deficient human fibroblasts
Davidson, J. S., Baumgarten, I. M., & Harley, E. H. (1984) · Experimental Cell Research · doi:10.1016/0014-4827(84)90580-9 · Cited by 11
Accelerated hepatic arginine transport in the tumor-bearing rat
Espat, N. J., Copeland, E. M., & Souba, W. W. (1994) · Annals of Surgical Oncology · doi:10.1007/bf02303559 · Cited by 10
Phase I/II study of arginine deiminase (ADI-PEG 20) in patients with advanced malignant melanoma (MM)
Ott, P. A., Carvajal, R. D., Pandit-Taskar, N. D., Jungbluth, A. A., Hoffman, E. W., Venhaus, R. R., Pan, L., Old, L. J., Pavlick, A. C., & Wolchok, J. D. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.15_suppl.9030 · Cited by 5
Extrinsic nitric oxide donor partially reverses arginine deiminase induced cell growth inhibition through NFκB and Bcl-XL
Seo, J. H., Sung, H. J., Choi, C. W., Kim, B. S., Shin, S. W., Kim, Y. H., Min, B.-H., & Kim, J. S. (2008) · Investigational New Drugs · doi:10.1007/s10637-007-9105-0 · Cited by 3

Sorted by citations

The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926
Autophagy and autophagy-related pathways in cancer
Debnath, J., Gammoh, N., & Ryan, K. M. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00585-z · Cited by 1,506
The hallmarks of cancer metabolism: still emerging
Pavlova, N. N., Zhu, J., & Thompson, C. B. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.01.007 · Cited by 1,418
mTOR signalling and cellular metabolism are mutual determinants in cancer
Mossmann, D., Park, S., & Hall, M. N. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0074-8 · Cited by 1,088
Targeting Metabolism for Cancer Therapy
Luengo, A., Gui, D. Y., & Vander Heiden, M. G. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.08.028 · Cited by 971

See all 441

Authors: Delage, B., Fennell, D. A., Nicholson, L., McNeish, I., Lemoine, N. R., Crook, T., & Szlosarek, P. W.
Affiliations: Queen Mary University of London (GB)
Queen's University Belfast (GB)
King's College London (GB)
St Bartholomew's Hospital (GB)
Imperial College London (GB)
Corresponding author: Szlosarek, Peter W.
ORCID: Delage, Barbara
Fennell, Dean A.
McNeish, Iain
Lemoine, Nicholas R.
Crook, Tim
Szlosarek, Peter W.
Venue: International Journal of Cancer
Publisher: Wiley
Published: 2010-04-09
Volume: 126
Issue: 12
Pages: 2762-2772
ISSN: 0020-7136 (ISSN-L)
1097-0215
DOI: 10.1002/ijc.25202
OpenAlex: W2027449497
Cited by: 441
References: 86
Citations by year: 2026: 26 · 2025: 38 · 2024: 28 · 2023: 30 · 2022: 32 · 2021: 51 · 2020: 26 · 2019: 35 · 2018: 32 · 2017: 26 · 2016: 25 · 2015: 20 · 2014: 25 · 2013: 17 · 2012: 12
FWCI: 1.61
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: International Journal of Cancer (publishedVersion)
PubMed (publishedVersion)
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
Research Portal (King's College London) (submittedVersion)
Leicester Research Archive (University of Leicester) (submittedVersion)
Research Portal (Queen's University Belfast) (submittedVersion)
Funders: Cancer Research UK (C12522/A8632, 12008)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Polyamine Metabolism and Applications
Keywords: arginine deprivation, argininosuccinate synthetase, ASS1, arginine auxotrophy, pegylated arginine deiminase, epigenetic silencing, chemoresistance, platinum resistance, ovarian cancer, tumor microenvironment, inflammatory cytokines, hepatocellular carcinoma, melanoma, malignant pleural mesothelioma, prostate cancer, kidney cancer, cancer therapy
MeSH terms: Animals, Arginine, Argininosuccinate Synthase, Humans, Neoplasms, Prognosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks